DK1981906T3 - Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse - Google Patents

Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse

Info

Publication number: DK1981906T3
Authority: DK; Denmark
Prior art keywords: peptides; sevi; promotion; viral infection; human sperm
Prior art date: 2006-01-25

Application number

DK07712110.1T

Other languages

English (en)

Inventor

Jan Muench

Ludger Staendker

Wolf-Georg Forssmann

Knut Adermann

Frank Kirchhoff

Elke Ruecker

Original Assignee

Viro Pharmaceuticals Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-01-25

Filing date

2007-01-25

Publication date

2011-01-10

2007-01-25 Application filed by Viro Pharmaceuticals Gmbh & Co Kg filed Critical Viro Pharmaceuticals Gmbh & Co Kg

2011-01-10 Application granted granted Critical

2011-01-10 Publication of DK1981906T3 publication Critical patent/DK1981906T3/da

Links

102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
208000036142 Viral infection Diseases 0.000 title 1
230000009385 viral infection Effects 0.000 title 1
208000031886 HIV Infections Diseases 0.000 abstract 1
101001001272 Homo sapiens Prostatic acid phosphatase Proteins 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Microbiology (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

DK07712110.1T 2006-01-25 2007-01-25 Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse DK1981906T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06100818		2006-01-25
PCT/EP2007/050727 WO2007085630A1 (en)	2006-01-25	2007-01-25	Human semen enhancer of viral infection peptides (sevi) and their use

Publications (1)

Publication Number	Publication Date
DK1981906T3 true DK1981906T3 (da)	2011-01-10

Family

ID=36423519

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07712110.1T DK1981906T3 (da)	2006-01-25	2007-01-25	Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse

Country Status (7)

Country	Link
US (1)	US8299031B2 (da)
EP (1)	EP1981906B1 (da)
JP (1)	JP2009524420A (da)
AT (1)	ATE461216T1 (da)
DE (1)	DE602007005354D1 (da)
DK (1)	DK1981906T3 (da)
WO (1)	WO2007085630A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2071024A1 (en) *	2007-12-14	2009-06-17	Pharis Biotec GmbH	Peptides of human prostatic acid phosphatase enhancing viral infectivity
CN104080799B (zh) *	2011-06-30	2021-03-12	吉尼松公司	具有病毒感染增强性质的肽及其用途
SG11201404361UA (en)	2012-01-26	2014-09-26	Life Technologies Corp	Methods for increasing the infectivity of viruses
WO2022004707A1 (ja) *	2020-06-30	2022-01-06	国立大学法人大阪大学	ＳＡＲＳ－ＣｏＶ－２吸着担体およびそれを含むカラム
EP4067375A1 (en) *	2021-03-30	2022-10-05	Universität Ulm	Fibril peptides
CN115708506B (zh) *	2022-11-14	2024-01-26	海南大学	一种马氏珠母贝精子低温保存方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6080409A (en) *	1995-12-28	2000-06-27	Dendreon Corporation	Immunostimulatory method
EP1911461B1 (en) *	2000-10-19	2011-12-07	Epimmune Inc.	HLA class I and II binding peptides and their uses
GB0406054D0 (en)	2004-03-17	2004-04-21	Univ Nottingham Trent	Prostatic acid phosphatase antigens

2007
- 2007-01-25 DK DK07712110.1T patent/DK1981906T3/da active
- 2007-01-25 DE DE602007005354T patent/DE602007005354D1/de active Active
- 2007-01-25 JP JP2008551787A patent/JP2009524420A/ja active Pending
- 2007-01-25 AT AT07712110T patent/ATE461216T1/de not_active IP Right Cessation
- 2007-01-25 WO PCT/EP2007/050727 patent/WO2007085630A1/en not_active Ceased
- 2007-01-25 US US12/162,093 patent/US8299031B2/en not_active Expired - Fee Related
- 2007-01-25 EP EP07712110A patent/EP1981906B1/en not_active Not-in-force

Also Published As

Publication number	Publication date
US20090191206A1 (en)	2009-07-30
EP1981906B1 (en)	2010-03-17
DE602007005354D1 (de)	2010-04-29
EP1981906A1 (en)	2008-10-22
HK1125386A1 (en)	2009-08-07
ATE461216T1 (de)	2010-04-15
WO2007085630A1 (en)	2007-08-02
US8299031B2 (en)	2012-10-30
JP2009524420A (ja)	2009-07-02

Similar Documents

Publication	Publication Date	Title
ES2563646T3 (es)	2016-03-15	Composiciones y métodos relacionados con variantes de la proteína A (SpA)
DK1981906T3 (da)	2011-01-10	Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse
EA201291243A1 (ru)	2013-08-30	Антитела против респираторно-синцитиального вируса (рсв) и способы их применения
EA201300125A1 (ru)	2013-12-30	Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии
CY1121687T1 (el)	2020-07-31	Αλληλουχιες αμινοξεων που κατευθυνονται εναντι των πρωτεϊνων φακελου ενος ioy και πολυπεπτιδια που τις περιεχουν για τη θεραπευτικη αντιμετωπιση ιικων νoσων
MX2012001882A (es)	2012-04-11	Anticuerpos contra el virus sincitial respiratorio (rsv) humano y metodos de uso.
EA201201116A1 (ru)	2013-03-29	Моноклональные антитела человека, полученные из в-клеток человека и обладающие нейтрализующей активностью против вирусов гриппа а
NO20076021L (no)	2008-01-28	Antistoffer rettet mot amyloid-betapeptid og metoder som anvender de samme
CY1118994T1 (el)	2018-01-10	Πρωτεϊνες συνδεσης αντιγονου il-17 υποδοχεα α
AR079114A1 (es)	2011-12-28	Proteinas de enlace de antigenos anti-orai1 y usos de las mismas
JP2009537143A5 (da)	2010-07-15
WO2009044273A3 (en)	2009-09-24	Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
ATE376559T1 (de)	2007-11-15	Methoden der verhinderung und behandlung der alzheimer'schen krankheit
EA201600476A1 (ru)	2016-11-30	Вариант вируса ppcc, клон кднк вируса ppcc европейского типа и их применение
EP2043622A4 (en)	2010-02-24	CANCER TREATMENT USING PROTEIN KINASE MODULATION BASED ON BETA
ATE543804T1 (de)	2012-02-15	Neue verbindungen
IL187321A (en)	2013-06-27	Host cell specific binding molecules encoding monoclonal antibodies capable of neutralizing viruses, pharmaceutical compositions comprising them and uses thereof in the preparation of medicaments
EA201170353A1 (ru)	2011-12-30	Антитела против гепатита с и их применение
DE502007006037D1 (de)	2011-02-03	Multimer zur immunstimulation
ATE554789T1 (de)	2012-05-15	Neues hundeinfluenza-virus und imfpstoff hierfür
DK2229440T3 (da)	2013-12-09	Rekombinante elastase-proteiner og fremgangsmåder til fremstilling og anvendelse deraf
DK2025750T3 (da)	2012-02-20	Targets og forbindelser til terapeutisk intervention af HIV-infektion
CY1114614T1 (el)	2016-10-05	Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
WO2008124176A3 (en)	2009-03-19	Soluble and membrane-anchored forms of lassa virus subunit proteins
EA200601219A1 (ru)	2006-12-29	Новые конденсированные пирролокарбазолы